Vitamin D and the 2024 Guideline Change

Why this comes up at all

Almost everyone who has looked into vitamin D has met the number 30.

Below 20 is deficient, 20 to 30 is insufficient, 30 and above is sufficient. That framework has driven a decade of supplement recommendations, a great many lab report interpretations, and an entire product category.

It came from a specific place: the 2011 Endocrine Society clinical practice guideline on evaluation, treatment and prevention of vitamin D deficiency, published in the Journal of Clinical Endocrinology and Metabolism.

In 2024 the same body published a communication in the same journal, and its title tells you the tone: Vitamin D Insufficiency and Epistemic Humility.

This brief exists because that change has propagated very unevenly. The 30 threshold is still quoted confidently across wellness writing, supplement marketing and a fair number of clinical conversations, by people who have no idea the organisation behind it stepped back.

What the guidance actually says now

The 2024 communication states that the Endocrine Society no longer endorses its previously proposed definitions of sufficiency at or above 30 ng/mL, or insufficiency between 20 and 30.

The stated reasoning is precise and worth reading carefully rather than paraphrasing loosely. In generally healthy populations, the available clinical trial evidence does not support assigning specific 25-hydroxyvitamin D thresholds that predict who benefits from supplementation.

That sentence is doing something narrower than it first appears, and it is easy to misread in both directions.

Worth separating one question the guideline change does not touch at all, because it is the more actionable one. Which form you take is settled in a way the threshold is not. A 2024 meta-analysis in Advances in Nutrition comparing D2 and D3 head to head across 20 randomized trials found D3 superior at raising total 25(OH)D, and a 2024 dose-response meta-analysis in Steroids pooling 33 study arms found D2 raises the total while decreasing 25(OH)D3 by 4.63 ng/mL. So D3 is the form to take, and that holds regardless of where anyone draws the line.

It does not say vitamin D is unimportant. It does not say deficiency is not real. It does not say supplementation never helps anyone.

It says the trials do not support drawing a confident line and declaring that everyone above it is fine and everyone below it should supplement.

That is a statement about thresholds and prediction, not about the nutrient.

What has not changed: genuinely low values, well below 20, remain associated with real bone and musculoskeletal consequences and are worth addressing.

What has changed is the confident middle. A result of 28, which for a decade triggered an automatic insufficiency label and a supplement recommendation, now sits in territory the guideline-issuing body has explicitly declined to define.

What this means in practice

The first practical consequence is about how to read your own result, and it is more useful than a replacement number would be.

Genuinely low, well under 20, is worth acting on with a provider, and it is worth asking why. Absorption, sun exposure, body composition and skin tone all affect it, and a supplement addresses the number without addressing the reason.

In the twenties or low thirties, the honest answer is that the evidence does not confidently tell you what to do. Sun exposure, food, and a conversation with someone who knows your situation beat a confident internet recommendation.

High, especially if you have been supplementing, is a real finding rather than a harmless one. Vitamin D is fat soluble, it accumulates, and high results deserve a doctor rather than being ignored because high vitamin D sounds benign.

The second consequence is about what else is in the picture. A 2018 randomized trial found magnesium supplementation changed vitamin D metabolism differently depending on baseline vitamin D, raising 25-hydroxyvitamin D3 when baseline was near 30 and lowering it when higher. So the number is not moved by dose alone.

And a 2026 randomized trial in JAMA Cardiology found two years of menaquinone-7 slowed coronary calcification progression against placebo, with the authors noting the clinical significance for plaque stability remains to be determined. Where calcium goes is a separate question from how much you absorb.

Third, and most practically: this is an argument for measuring rather than for guessing in either direction.

The honest hedge

I am not a doctor and I am not diagnosing anyone.

I want to be careful not to let this brief become an argument that vitamin D does not matter, because that is the wrong conclusion and it is the easy one to reach from a headline about a withdrawn threshold.

The Endocrine Society did not withdraw vitamin D. It withdrew a specific numerical framework on the grounds that the trials do not support it, which is what a scientific body is supposed to do when the evidence does not hold up.

I find that genuinely admirable and I also find it uncomfortable, because a great deal of confident advice, including advice I have seen repeated in this industry for years, rested on numbers that the issuing body has now stepped back from.

There is a practical caution in the other direction too. Vitamin D is fat soluble and accumulates, so it is possible to take too much over a long enough period. Anyone who has been taking a high dose for years on the strength of general advice rather than a measurement should measure.

Certain groups still have well-established reasons to pay attention: people at northern latitudes, testing in winter, with darker skin, with limited sun exposure, or with a gut condition affecting fat absorption.

None of that requires a threshold to be true.

What to do with this

Take D3, not D2. Separate from the threshold argument entirely, and the clearest practical instruction here. A 2024 meta-analysis of 20 comparative trials found D3 raises total 25(OH)D more effectively, and a 2024 dose-response meta-analysis found D2 supplementation lowers the 25(OH)D3 fraction by 4.63 ng/mL even as it lifts the total. Look for cholecalciferol on the label rather than ergocalciferol.

Stop quoting 30 as settled. The body that proposed it explicitly no longer endorses it, and repeating it as established is now inaccurate rather than merely confident.

Measure rather than guess in either direction. A vitamin D test measures 25-hydroxy vitamin D, which is the storage form and the right one for status.

Act on genuinely low. Well under 20 is worth addressing with a provider, and worth asking why rather than only what to take.

Hold the middle loosely. In the twenties and low thirties, the evidence does not confidently tell you what to do, and pretending otherwise is what the 2024 communication was correcting.

Take a high result seriously. Vitamin D accumulates, so high is a real finding rather than a harmless one, particularly if you have been supplementing for years.

Remember the cofactors. Magnesium affects vitamin D metabolism, and K2 is about where the calcium ends up.

Recheck after about three months if you change anything. The storage form moves slowly, so testing sooner mostly measures noise.

Where the paid report goes further

This page covers what the published evidence says in general. It cannot tell you what it means for you, because it does not know your medications, your labs, your history, or your dose.

A paid research report does that work. Jess builds it around your actual situation, walks the citations, and writes what the evidence supports for someone in your position. The brief is the shorter version. The deep dive is the one where every citation is read and the reasoning is laid out end to end, and Jess reviews every deep dive personally before it goes out.

Neither is medical advice, and neither replaces your prescriber. What they replace is the evening you would otherwise spend trying to work out which of forty search results is telling you the truth.